Cargando…
Next-generation antithrombotics in ischemic stroke: preclinical perspective on ‘bleeding-free antithrombosis'
The present antithrombotic drugs used to treat or prevent ischemic stroke have significant limitations: either they show only moderate efficacy (platelet inhibitors), or they significantly increase the risk for hemorrhages (thrombolytics, anticoagulants). Although most strokes are caused by thrombot...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3463876/ https://www.ncbi.nlm.nih.gov/pubmed/22805877 http://dx.doi.org/10.1038/jcbfm.2012.108 |